William Plovanic Analyst PerformanceMed-Tech Operator and Investment Professional at Canaccord Genuity GroupWilliam Plovanic is a stock analyst at Canaccord Genuity Group focused in the healthcare sector, covering 31 publicly traded companies. Over the past year, William Plovanic has issued 69 stock ratings, including buy and hold recommendations. While full access to William Plovanic's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights William Plovanic's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings182 Last 12 YearsBuy Recommendations86.47% 147 Buy RatingsCompanies Covered31 Unique Companies Ratings Distribution170RatingsDistribution of strong buy, buy, hold, and sell ratings by William Plovanic.RatingPercentageCount Strong Buy0.0%0 ratings Buy86.5%147 ratings Hold13.5%23 ratings Sell0.0%0 ratingsOut of 170 total stock ratings issued by William Plovanic at Canaccord Genuity Group, the majority (86.5%) have been Buy recommendations, followed by 13.5% Hold.Best & Worst CallsBest Call0000.0%TMDXMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%AFIBNov 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ67.7% of companies on NASDAQ21 companiesNYSE29.0% of companies on NYSE9 companiesOTCMKTS3.2% of companies on OTCMKTS1 companyWilliam Plovanic, an analyst at Canaccord Genuity Group, currently covers 31 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare30 companies96.8%Technology1 company3.2%William Plovanic of Canaccord Genuity Group specializes in stock coverage within the Healthcare sector, with additional focus on Technology companies.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES27 companies87.1%BIOTECHNOLOGY2 companies6.5%HEALTHCARE TECHNOLOGY1 company3.2%ELECTROMEDICAL EQUIPMENT1 company3.2% William Plovanic's Ratings History at Canaccord Genuity Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsAORTArtivion8/18/2026Boost Price Target$28.36$40.00Buy$0.0000.00% ROIHTFLHeartflow8/14/2026Boost Price Target$41.08$45.00Buy$0.0000.00% ROICBLLCeriBell8/11/2026Boost Price Target$19.30$26.00Buy$0.0000.00% ROIPLSEPulse Biosciences8/10/2026Boost Price Target$42.41$43.00Buy$0.0000.00% ROITNDMTandem Diabetes Care8/7/2026Set Price Target$19.99$40.00$0.0000.00% ROIAORTArtivion8/7/2026Set Price Target$26.54$39.00$0.0000.00% ROIPODDInsulet8/6/2026Lower Price Target$133.26$179.00Buy$0.0000.00% ROIDXCMDexCom8/3/2026Set Price Target$86.87$90.00Buy$0.0000.00% ROIBSXBoston Scientific7/30/2026Lower Price Target$44.75$66.00Buy$0.0000.00% ROITMDXTransMedics Group6/30/2026Reiterated Rating$65.56$124.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AORTArtivion6/16/2026Reiterated Rating$20.98$36.00Buy$0.0000.00% ROIPLSEPulse Biosciences6/4/2026Initiated Coverage$24.99$32.00Buy$0.0000.00% ROIBSXBoston Scientific6/1/2026Lower Price Target$48.54$70.00Buy$0.0000.00% ROIIRTCiRhythm Technologies6/1/2026Lower Price Target$113.36$152.00Buy$0.0000.00% ROIDXCMDexCom5/18/2026Set Price Target$64.85$82.00Buy$0.0000.00% ROIHTFLHeartflow5/15/2026Lower Price Target$32.24$37.00Buy$0.0000.00% ROICBLLCeriBell5/12/2026Lower Price Target$20.06$25.00Buy$0.0000.00% ROIPODDInsulet5/7/2026Lower Price Target$151.28$249.00Buy$0.0000.00% ROIATRCAtriCure5/6/2026Boost Price Target$28.32$55.00Buy$0.0000.00% ROITMDXTransMedics Group5/6/2026Lower Price Target$72.92$124.00Buy$0.0000.00% ROIDXCMDexCom5/1/2026Set Price Target$59.55$100.00Buy$0.0000.00% ROIIRTCiRhythm Technologies5/1/2026Lower Price Target$120.80$180.00Buy$0.0000.00% ROIEWEdwards Lifesciences4/24/2026Set Price Target$83.25$85.00Hold$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$65.78$71.00Buy$0.0000.00% ROICVRXCVRx4/14/2026Reiterated Rating$8.00$10.00Buy$0.0000.00% ROIHTFLHeartflow3/19/2026Boost Price Target$25.03$43.00Buy$0.0000.00% ROISTIMNeuronetics3/19/2026Lower Price Target$1.43$3.00Buy$0.0000.00% ROIHTFLHeartflow3/9/2026Reiterated Rating$23.30$40.00Buy$0.0000.00% ROITLSITriSalus Life Sciences3/6/2026Lower Price Target$4.44$7.00Buy$0.0000.00% ROIIRTCiRhythm Technologies2/20/2026Lower Price Target$150.48$198.00Buy$0.0000.00% ROIATRCAtriCure2/18/2026Lower Price Target$31.32$53.00Buy$0.0000.00% ROIBSXBoston Scientific2/17/2026Lower Price Target$76.28$109.00Buy$0.0000.00% ROIDXCMDexCom2/13/2026Set Price Target$70.54$95.00Buy$0.0000.00% ROICVRXCVRx2/13/2026Lower Price Target$5.69$10.00Buy$0.0000.00% ROIAORTArtivion2/13/2026Lower Price Target$35.51$48.00Buy$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$112.00Buy$0.0000.00% ROISIBNSiBone12/17/2025Boost Price Target$19.51$27.00Buy$0.0000.00% ROITNDMTandem Diabetes Care12/17/2025Set Price Target$22.60$35.00Buy$0.0000.00% ROIPENPenumbra12/17/2025Boost Price Target$308.27$359.00Buy$0.0000.00% ROIEWEdwards Lifesciences12/17/2025Set Price Target$85.56$87.00Hold$0.0000.00% ROISmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.Click here to learn this company's name for free todayBSXBoston Scientific12/17/2025Lower Price Target$95.02$131.00Buy$0.0000.00% ROIAORTArtivion12/17/2025Reiterated Rating$46.04$51.00Buy$0.0000.00% ROIPODDInsulet12/17/2025Boost Price Target$288.73$450.00Buy$0.0000.00% ROICBLLCeriBell12/17/2025Boost Price Target$21.74$30.00Buy$0.0000.00% ROITMDXTransMedics Group12/17/2025Boost Price Target$122.75$148.00Buy$0.0000.00% ROITLSITriSalus Life Sciences12/17/2025Boost Price Target$7.31$12.00Buy$0.0000.00% ROIEWEdwards Lifesciences12/5/2025Set Price Target$85.72$89.00$0.0000.00% ROIEWEdwards Lifesciences12/5/2025Reiterated Rating$85.72$89.00Hold$0.0000.00% ROIPODDInsulet11/24/2025Boost Price Target$331.17$432.00Buy$0.0000.00% ROIHTFLHeartflow11/13/2025Boost Price Target$31.66$40.00Buy$0.0000.00% ROIAORTArtivion11/7/2025Boost Price Target$44.82$51.00Buy$0.0000.00% ROIPODDInsulet11/7/2025Boost Price Target$319.82$428.00Buy$0.0000.00% ROIPENPenumbra11/6/2025Boost Price Target$265.79$355.00Buy$0.0000.00% ROICVRXCVRx11/6/2025Boost Price Target$10.00$11.00Buy$0.0000.00% ROIEWEdwards Lifesciences11/3/2025Reiterated Rating$82.48$84.00Hold$0.0000.00% ROIDXCMDexCom10/31/2025Set Price Target$68.20$99.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/31/2025Boost Price Target$187.30$212.00Buy$0.0000.00% ROIATRCAtriCure10/30/2025Boost Price Target$35.44$64.00Buy$0.0000.00% ROITMDXTransMedics Group10/30/2025Boost Price Target$134.32$147.00Buy$0.0000.00% ROIBSXBoston Scientific10/23/2025Reiterated Rating$103.66$132.00Buy$0.0000.00% ROITMDXTransMedics Group10/14/2025Reiterated Rating$111.38$142.00Buy$0.0000.00% ROIBSXBoston Scientific10/1/2025Boost Price Target$97.55$132.00Buy$0.0000.00% ROIPODDInsulet9/29/2025Boost Price Target$318.00$399.00Buy$0.0000.00% ROIIRTCiRhythm Technologies9/29/2025Boost Price Target$170.81$193.00Buy$0.0000.00% ROIAORTArtivion9/29/2025Boost Price Target$40.98$50.00Buy$0.0000.00% ROITNDMTandem Diabetes Care9/29/2025Reiterated Rating$11.85$24.00Buy$0.0000.00% ROIDXCMDexCom9/29/2025Reiterated Rating$66.14$106.00Buy$0.0000.00% ROIHTFLHeartflow9/22/2025Boost Price Target$32.88$39.00Buy$0.0000.00% ROIHTFLHeartflow9/2/2025Initiated Coverage$31.50$35.00Buy$0.0000.00% ROIPODDInsulet8/8/2025Boost Price Target$307.10$353.00Buy$000.0000.00% ROIAORTArtivion8/8/2025Boost Price Target$40.89$41.00Buy$00.0000.00% ROITNDMTandem Diabetes Care8/7/2025Set Price Target$11.18$24.00Buy$00.0000.00% ROISTIMNeuronetics8/6/2025Lower Price Target$4.21$7.00Buy$0.0000.00% ROIDXCMDexCom8/1/2025Reiterated Rating$80.05$106.00Buy$00.0000.00% ROIIRTCiRhythm Technologies8/1/2025Boost Price Target$165.04$170.00Buy$000.0000.00% ROIEWEdwards Lifesciences7/25/2025Boost Price Target$79.13$81.00Hold$00.0000.00% ROIGMEDGlobus Medical7/22/2025Lower Price Target$53.16$90.00Buy$00.0000.00% ROIANGOAngioDynamics7/16/2025Boost Price Target$8.65$17.00Buy$00.0000.00% ROITMDXTransMedics Group7/15/2025Boost Price Target$116.94$142.00Buy$00.0000.00% ROIAORTArtivion6/17/2025Initiated Coverage$28.68$35.00Buy$00.0000.00% ROIZBHZimmer Biomet5/12/2025Lower Price Target$98.77$101.00Hold$00.0000.00% ROIIRTCiRhythm Technologies5/2/2025Lower Price Target$131.55$139.00Buy$000.0000.00% ROIDXCMDexCom5/2/2025Boost Price Target$81.75$106.00Buy$00.0000.00% ROITNDMTandem Diabetes Care5/1/2025Boost Price Target$19.98$59.00Buy$00.0000.00% ROIEWEdwards Lifesciences4/25/2025Boost Price Target$75.15$75.00Hold$00.0000.00% ROICVRXCVRx4/8/2025Lower Price Target$11.54$18.00Buy$0.0000.00% ROIATRCAtriCure3/28/2025Lower Price Target$34.37$52.00Buy$00.0000.00% ROITLSITriSalus Life Sciences3/28/2025Reiterated Rating$5.44$11.00Buy$0.0000.00% ROITMDXTransMedics Group3/11/2025Reiterated Rating$67.54$104.00Buy$000.0000.00% ROISTIMNeuronetics3/5/2025Boost Price Target$5.42$8.00Buy$0.0000.00% ROIReady to give options a try? Your first trade (Ticker included) -INSIDE (Ad)Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.CBLLCeriBell2/26/2025Reiterated Rating$25.90$33.00Buy$00.0000.00% ROITNDMTandem Diabetes Care2/26/2025Reiterated Rating$33.83$63.00Buy$00.0000.00% ROIDXCMDexCom2/14/2025Boost Price Target$84.09$103.00Buy$00.0000.00% ROIEWEdwards Lifesciences2/13/2025Boost Price Target$75.83$71.00Hold$00.0000.00% ROIATRCAtriCure2/13/2025Boost Price Target$42.36$66.00Buy$00.0000.00% ROICVRXCVRx2/5/2025Boost Price Target$16.25$23.00Buy$0.0000.00% ROIGMEDGlobus Medical1/10/2025Boost Price Target$88.42$101.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupUBS GroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
